Pamela L. Kunz, MD
Associate Professor of Internal Medicine (Medical Oncology); Director, Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center; Chief, GI Medical Oncology; Vice Chief, Diversity, Equity, and Inclusion, Medical Oncology
Biography
Research & Publications
Patient Care
News
Locations
Appointments
Biography
Dr. Kunz specializes in the treatment of gastrointestinal malignancies. Her research involves clinical trials and epidemiologic studies, primarily in neuroendocrine and gastroesophageal cancers. She is an international leader in the clinical care of patients with neuroendocrine tumors (NETs) and is advancing the field through clinical trials and translational science that are defining the next generation of therapies for patients with this rare diagnosis. She is the current president of the North American Neuroendocrine Tumor Society (NANETS).
Education & Training
- Oncology FellowStanford University (2008)
- Chief ResidentStanford University (2005)
- Internal Medicine ResidentStanford University (2004)
- MDDartmouth Medical School (2001)
- BADartmouth College, Biology (1994)
Departments & Organizations
- Center for Gastrointestinal Cancers
- Developmental Therapeutics
- Internal Medicine
- Medical Oncology
- Office of DEI in Medicine
- Status of Women in Medicine Committee (SWIM)
- Subset Medical Oncology Faculty
- WHRY Pilot Project Program Investigators
- Women's Health Research at Yale
- Yale Cancer Center
- Yale Medicine
- YCC Diversity, Equity, and Inclusion